Literature DB >> 11493480

Natural history of congenital dyserythropoietic anemia type II.

A Iolascon1, J Delaunay, S N Wickramasinghe, S Perrotta, M Gigante, C Camaschella.   

Abstract

Congenital dyserythropoietic anemia type II (CDA-II) is an autosomal recessive disease characterized by anemia, jaundice, splenomegaly, and erythroblast multinuclearity. The natural history of the disease is unknown. The frequency, the relevance of complications, and the use of splenectomy are poorly defined. This study examined 98 patients from unrelated families enrolled in the International Registry of CDA-II. Retrospective data were obtained using an appropriate questionnaire. The mean age at presentation was 5.2 +/- 6.1 years. Anemia was present in 66% and jaundice in 53.4% of cases. The mean age at correct diagnosis was 15.9 +/- 11.8 years. Twenty-three percent of patients for whom data were available developed anemia during the neonatal period, and 10 of these individuals required transfusions. Splenectomy produced an increased hemoglobin (P <.001) and a reduced bilirubin level (P =.007) in comparison with values before splenectomy. Preliminary data indicate that iron overload occurs irrespective of the hemochromatosis genotype. (Blood. 2001;98:1258-1260)

Entities:  

Mesh:

Year:  2001        PMID: 11493480     DOI: 10.1182/blood.v98.4.1258

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Molecular basis of congenital dyserythropoietic anemia type II and genotype-phenotype relationship.

Authors:  Mario Cazzola; Rosangela Invernizzi
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

2.  Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II.

Authors:  Achille Iolascon; Jean Delaunay
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

3.  Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow Transplantation.

Authors:  Maurizio Miano; Dirk-Jan Eikema; Mahmoud Aljurf; Pieter J Van't Veer; Gülyüz Öztürk; Matthias Wölfl; Frans Smiers; Angsar Schulz; Gerard Socié; Kim Vettenranta; Cristina Diaz de Heredia; Marco Zecca; Johan Maertens; Montserrat Rovira; Jorge Sierra; Duygu Uckan-Cetinkaya; Elena Skorobogatova; Ali Bülent Antmen; Jean-Hugues Dalle; Miroslaw Markiewicz; Rose Marie Hamladji; Vassiliki Kitra-Roussou; Giorgio La Nasa; Gergely Kriván; Amal Al-Seiraihy; Stefano Giardino; Antonio Maria Risitano; Regis Peffault de Latour; Carlo Dufour
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

4.  Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.

Authors:  Orly Dgany; Nili Avidan; Jean Delaunay; Tatyana Krasnov; Lea Shalmon; Hanna Shalev; Tal Eidelitz-Markus; Joseph Kapelushnik; Daniel Cattan; Alexandre Pariente; Michel Tulliez; Aurore Crétien; Pierre-Olivier Schischmanoff; Achille Iolascon; Eithan Fibach; Ariel Koren; Jochen Rössler; Martine Le Merrer; Isaac Yaniv; Rina Zaizov; Edna Ben-Asher; Tsvyia Olender; Doron Lancet; Jacques S Beckmann; Hannah Tamary
Journal:  Am J Hum Genet       Date:  2002-11-14       Impact factor: 11.025

5.  Congenital dyserythropoietic anemia.

Authors:  Takahiro Kamiya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

6.  Congenital dyserythropoietic anaemia type II: a rare entity.

Authors:  Kiran Alam; Mehar Aziz; Manoranjan Varshney; Veena Maheshwari; Mahfooz Basha; Kavita Gaur
Journal:  BMJ Case Rep       Date:  2011-04-19

7.  Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).

Authors:  Jonas Denecke; Christian Kranz; Manfred Nimtz; Harald S Conradt; Thomas Brune; Hermann Heimpel; Thorsten Marquardt
Journal:  Glycoconj J       Date:  2007-12-29       Impact factor: 2.916

8.  Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.

Authors:  Hisanori Fujino; Sayoko Doisaki; Young-Dong Park; Asahito Hama; Hideki Muramatsu; Seiji Kojima; Shinichi Sumimoto
Journal:  Int J Hematol       Date:  2013-04-19       Impact factor: 2.490

Review 9.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.

Authors:  T Marquardt; J Denecke
Journal:  Eur J Pediatr       Date:  2003-03-15       Impact factor: 3.183

10.  Congenital dyserythropoietic anemia type II - a case report of two siblings in a family.

Authors:  Khaidem Ibochouba Singh; Jigme Tenzing Shartsho; Waikhom Ruhini Kumar Singh; Raj Kumari Tamphasana Devi; Ahongshangbam Meina Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2008-03-19       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.